Monday, February 19, 2024

 6-8 pm

Towson University

Science Complex – Room 3333

Special Guest: Nikki Goodwin

Accelerating Medicinal Chemistry through Modern High Throughput Experimentation

Dinner will be served. Cost to enjoy a meal is $20.

Please RSVP by Monday, February 12th to Sara at snarayan5@yahoo.com

Nicole (Nikki) Goodwin received a B.S. with honors in chemistry from the University of Delaware where a two year undergraduate research experience with Douglass F. Taber cemented her interested in organic chemistry.  She subsequently earned her Ph.D. from Caltech working with 2022 Nobel Laureate David W.C. MacMillan on the development of novel organocatalytic strategies as applied to the syntheses of the spiculisporic acids and cylindrocyclophanes.  After graduation, Nikki started her industrial career as a medicinal chemist at Lexicon Pharmaceuticals in Princeton, NJ where she most notably was an team member and inventor of Inpefa™ (sotagliflozin), an FDA-approved dual SGLT1/2 inhibitor for heart failure.  In 2014, Nikki transitioned from the biotech sector to big pharma with a move to GSK where she is currently a director in Medicinal Chemistry focusing on the development and utilization of platform technologies and high throughput experimentation.  Over the course of her career, Nikki has worked in a variety of therpeuetic areas, including metabolic diseases, opthalmology, immunology, and respiratory.   She is an active member of the American Chemical Society and is the Industrial Vice Chair for the MEDI Division.  Nikki was recently recognized by the ACS as one of its 2022 WCC Rising Stars.  Growing up in southern New Jersey outside of Philadelphia, Nikki will never turn down a good pretzel or cheesesteak!